{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:35:57Z","timestamp":1792989357768,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.drudis.2026.104841","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:11:49Z","timestamp":1792797109000},"page":"104841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aptamer-based therapeutics for malaria and neglected tropical diseases"],"prefix":"10.1016","author":[{"given":"Tri","family":"Lestari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmud I.","family":"Bako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyssa I.A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiho","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3729-2284","authenticated-orcid":false,"given":"Ji-Young","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104841_b0005","unstructured":"World Health Organization. World Malaria Report 2025: Addressing the Threat of Antimalarial Drug Resistance. Geneva: World Health Organization; 2025"},{"key":"10.1016\/j.drudis.2026.104841_b0010","series-title":"Global Report on Neglected Tropical Diseases 2025","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.drudis.2026.104841_b0015","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.3390\/jcm13195680","article-title":"Global fight against malaria: goals and achievements 1900-2022","volume":"13","author":"Thellier","year":"2024","journal-title":"J Clin Med."},{"key":"10.1016\/j.drudis.2026.104841_b0020","unstructured":"World Health Organization. Global Health Observatory: NTD interventions, people requiring interventions against NTDs, number. Accessed 10 June 2026. https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/reported-number-of-people-requiring-interventions-against-ntds; 2024."},{"key":"10.1016\/j.drudis.2026.104841_b0025","unstructured":"World Health Organization. Global Health Observatory: malaria. Accessed 10 June 2026. https:\/\/www.who.int\/data\/gho\/data\/themes\/malaria; 2024."},{"key":"10.1016\/j.drudis.2026.104841_b0030","article-title":"Global epidemiological trends, distribution of NTDs and malaria, and disease burden projections for the next 15 years","volume":"14","author":"Huang","year":"2026","journal-title":"Front Public Health."},{"key":"10.1016\/j.drudis.2026.104841_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013165","article-title":"Examining the overlap in lymphatic filariasis prevalence and malaria insecticide-treated net access-use in endemic Africa","volume":"19","author":"Whisnant","year":"2025","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.drudis.2026.104841_b0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s13071-026-07309-0","article-title":"Forgotten in the tropics: research on Culex mosquitoes is overshadowed in malaria and dengue-endemic regions","volume":"19","author":"Abdi","year":"2026","journal-title":"Parasit Vectors."},{"key":"10.1016\/j.drudis.2026.104841_b0045","article-title":"An update on prevention of malaria in travelers","volume":"8","author":"Agudelo Higuita","year":"2021","journal-title":"Ther Adv Infect Dis."},{"key":"10.1016\/j.drudis.2026.104841_b0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41598-017-00322-5","article-title":"Short-course, high-dose rifampicin achieves Wolbachia depletion predictive of curative outcomes in preclinical models of lymphatic filariasis and onchocerciasis","volume":"7","author":"Aljayyoussi","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.drudis.2026.104841_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2026.1742086","article-title":"Neglected tropical diseases: recent trends and challenges associated with its rapid diagnosis and effective therapeutic strategies","volume":"17","author":"Kumar","year":"2026","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.drudis.2026.104841_b0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-013439","article-title":"Mass drug administration for neglected tropical disease control and elimination: a systematic review of ethical reasons","volume":"9","author":"Hoefle-B\u00e9nard","year":"2024","journal-title":"BMJ Glob Health."},{"key":"10.1016\/j.drudis.2026.104841_b0065","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s13273-023-00384-9","article-title":"In silico molecular docking validation of procalcitonin-binding aptamer and sepsis diagnosis","volume":"19","author":"Park","year":"2023","journal-title":"Mol Cell Toxicol."},{"key":"10.1016\/j.drudis.2026.104841_b0070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/bios10080098","article-title":"Docking simulation and sandwich assay for aptamer-based botulinum neurotoxin type C detection","volume":"10","author":"Oh","year":"2020","journal-title":"Biosensors (Basel)."},{"key":"10.1016\/j.drudis.2026.104841_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152960","article-title":"Aptamers and endocytosis: the path into tumor cells","volume":"791","author":"Dzarieva","year":"2025","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1016\/j.drudis.2026.104841_b0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41699-021-00202-7","article-title":"2D graphene oxide\u2013aptamer conjugate materials for cancer diagnosis","volume":"5","author":"Sekhon","year":"2021","journal-title":"Npj 2D Mater Appl."},{"key":"10.1016\/j.drudis.2026.104841_b0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1021\/acscombsci.7b00190","article-title":"Aptamer-based paper strip sensor for detecting Vibrio fischeri","volume":"20","author":"Shin","year":"2018","journal-title":"ACS Comb Sci."},{"key":"10.1016\/j.drudis.2026.104841_b0090","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s13273-025-00601-7","article-title":"Development of an aptamer-based diagnostic method targeting PRRSV-induced cytopathic effects","volume":"22","author":"Oh","year":"2026","journal-title":"Mol Cell Toxicol."},{"key":"10.1016\/j.drudis.2026.104841_b0095","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1039\/D5SC06966A","article-title":"Navigating the next frontier in biomedicine: breakthroughs and insights in nucleic acid therapeutics","volume":"17","author":"Wu","year":"2026","journal-title":"Chem Sci."},{"key":"10.1016\/j.drudis.2026.104841_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.972933","article-title":"Recent advances in aptamer-based targeted drug delivery systems for cancer therapy","volume":"10","author":"Gao","year":"2022","journal-title":"Front Bioeng Biotechnol."},{"key":"10.1016\/j.drudis.2026.104841_b0105","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1073\/pnas.0906370106","article-title":"Inhibiting Plasmodium falciparum growth and heme detoxification pathway using heme-binding DNA aptamers","volume":"106","author":"Niles","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2026.104841_b0110","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00436-009-1583-x","article-title":"In vitro selection of RNA aptamers against a conserved region of the Plasmodium falciparum erythrocyte membrane protein 1","volume":"105","author":"Barfod","year":"2009","journal-title":"Parasitol Res."},{"key":"10.1016\/j.drudis.2026.104841_b0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/2221-1691.273091","article-title":"Evolution of specific RNA aptamers via SELEX targeting recombinant human CD36 protein: a candidate therapeutic target in severe malaria","volume":"10","author":"Nik Kamarudin","year":"2020","journal-title":"Asian Pac J Trop Biomed."},{"key":"10.1016\/j.drudis.2026.104841_b0120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biochi.2023.06.011","article-title":"RNA aptamers developed against tRip: a preliminary approach targeting tRNA entry in Plasmodium","volume":"217","author":"Pitolli","year":"2024","journal-title":"Biochimie."},{"key":"10.1016\/j.drudis.2026.104841_b0125","article-title":"Selection and characterization of DNA aptamers targeting all four serotypes of dengue viruses","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.drudis.2026.104841_b0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10529-017-2462-7","article-title":"Development of RNA aptamer that inhibits methyltransferase activity of dengue virus","volume":"40","author":"Jung","year":"2018","journal-title":"Biotechnol Lett."},{"key":"10.1016\/j.drudis.2026.104841_b0135","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.02095-24","article-title":"Generation of RNA aptamers against chikungunya virus E2 envelope protein","volume":"99","author":"Goto","year":"2025","journal-title":"J Virol."},{"key":"10.1016\/j.drudis.2026.104841_b0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.toxicon.2021.09.026","article-title":"Neutralization of Daboxin P activities by rationally designed aptamers","volume":"203","author":"Devi","year":"2021","journal-title":"Toxicon."},{"key":"10.1016\/j.drudis.2026.104841_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132240","article-title":"Development and optimization of a DNA aptamer to delay \u03b2-bungarotoxin-induced lethality in a rodent model","volume":"270","author":"Liu","year":"2024","journal-title":"Int J Biol Macromol."},{"key":"10.1016\/j.drudis.2026.104841_b0150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.biochi.2024.12.011","article-title":"The neutralisation and inhibitory effects of new tRNA-mimetic aptamer against cytotoxin-induced cytotoxicity in human skin keratinocytes","volume":"231","author":"Hiu","year":"2025","journal-title":"Biochimie."},{"key":"10.1016\/j.drudis.2026.104841_b0155","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/toxins14070469","article-title":"Exploring the utility of ssDNA aptamers directed against snake venom toxins as new therapeutics for snakebite envenoming","volume":"14","author":"Alomran","year":"2022","journal-title":"Toxins (Basel)."},{"key":"10.1016\/j.drudis.2026.104841_b0160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12936-025-05492-6","article-title":"The burden of malaria in East Africa: prevalence, risk factors, and control strategies","volume":"24","author":"Bashir","year":"2025","journal-title":"Malar J."},{"key":"10.1016\/j.drudis.2026.104841_b0165","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00109-24","article-title":"Artemisinin-resistant malaria","volume":"37","author":"White","year":"2024","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.drudis.2026.104841_b0170","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/pharmaceutics16111416","article-title":"Recent advances in the treatment of malaria","volume":"16","author":"Alghamdi","year":"2024","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.drudis.2026.104841_b0175","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02781-21","article-title":"Bazedoxifene, a postmenopausal drug, acts as an antimalarial and inhibits hemozoin formation","volume":"10","author":"Sudhakar","year":"2022","journal-title":"Microbiol Spectr."},{"key":"10.1016\/j.drudis.2026.104841_b0180","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/s42003-025-08991-z","article-title":"Heme processing in the malaria parasite, Plasmodium falciparum: a time-dependent basal-level analysis","volume":"8","author":"Garnie","year":"2025","journal-title":"Commun Biol."},{"key":"10.1016\/j.drudis.2026.104841_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295053","article-title":"Different PfEMP1-expressing Plasmodium falciparum variants induce divergent endothelial transcriptional responses during co-culture","volume":"18","author":"Othman","year":"2023","journal-title":"PLoS One."},{"key":"10.1016\/j.drudis.2026.104841_b0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/tropicalmed8070353","article-title":"Knobs, adhesion, and severe falciparum malaria","volume":"8","author":"Wiser","year":"2023","journal-title":"Trop Med Infect Dis."},{"key":"10.1016\/j.drudis.2026.104841_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.813011","article-title":"Plasmodium falciparum parasite lines expressing DC8 and group A PfEMP1 bind to brain, intestinal, and kidney endothelial cells","volume":"12","author":"Ortolan","year":"2022","journal-title":"Front Cell Infect Microbiol."},{"key":"10.1016\/j.drudis.2026.104841_b0200","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/jnen\/nlaf104","article-title":"Mapping the expression of endothelial adhesion receptors for Plasmodium falciparum-infected erythrocytes in fatal cerebral malaria in Malawian children","volume":"84","author":"Dorovini-Zis","year":"2025","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.drudis.2026.104841_b0205","doi-asserted-by":"crossref","first-page":"10618","DOI":"10.1093\/nar\/gkab769","article-title":"Identification of host tRNAs preferentially recognized by the Plasmodium surface protein tRip","volume":"49","author":"Cela","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drudis.2026.104841_b0210","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.jiph.2023.08.001","article-title":"Dengue overview: an updated systemic review","volume":"16","author":"Khan","year":"2023","journal-title":"J Infect Public Health."},{"key":"10.1016\/j.drudis.2026.104841_b0215","series-title":"Dengue Virus Evolution: From Emergence to a Global Health Crisis","first-page":"287","article-title":"Antiviral strategies against dengue virus: recent insights into compounds targeting viral and host factors","author":"Rakotoarimanana","year":"2025"},{"key":"10.1016\/j.drudis.2026.104841_b0220","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-023-05790-6","article-title":"Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates","volume":"615","author":"Goethals","year":"2023","journal-title":"Nature."},{"key":"10.1016\/j.drudis.2026.104841_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2024.105710","article-title":"Dengue virus: etiology, epidemiology, pathobiology, and developments in diagnosis and control \u2013 a comprehensive review","volume":"127","author":"Pourzangiabadi","year":"2025","journal-title":"Infect Genet Evol."},{"key":"10.1016\/j.drudis.2026.104841_b0230","doi-asserted-by":"crossref","first-page":"11959","DOI":"10.3390\/molecules200711959","article-title":"A highlight of recent advances in aptamer technology and its application","volume":"20","author":"Sun","year":"2015","journal-title":"Molecules."},{"key":"10.1016\/j.drudis.2026.104841_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1413250","article-title":"Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventions","volume":"15","author":"Shaikh","year":"2024","journal-title":"Front Microbiol."},{"key":"10.1016\/j.drudis.2026.104841_b0240","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1007\/s00253-020-10437-x","article-title":"Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection","volume":"104","author":"Kumar","year":"2020","journal-title":"Appl Microbiol Biotechnol."},{"key":"10.1016\/j.drudis.2026.104841_b0245","first-page":"55","article-title":"Development and application of treatment for chikungunya fever","volume":"13","author":"Millsapps","year":"2022","journal-title":"Res Rep Trop Med."},{"key":"10.1016\/j.drudis.2026.104841_b0250","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jiw391","article-title":"Chikungunya: its history in Africa and Asia and its spread to new regions in 2013-2014","volume":"214","author":"Zeller","year":"2016","journal-title":"J Infect Dis."},{"key":"10.1016\/j.drudis.2026.104841_b0255","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/trstmh\/trae145","article-title":"What is new in the treatment of snakebite envenoming? Opportunities and challenges","volume":"119","author":"Warrell","year":"2025","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"10.1016\/j.drudis.2026.104841_b0260","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/bcp.12739","article-title":"Adverse reactions to snake antivenom, and their prevention and treatment","volume":"81","author":"de Silva","year":"2016","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.drudis.2026.104841_b0265","doi-asserted-by":"crossref","first-page":"11328","DOI":"10.1038\/s41598-022-13376-x","article-title":"Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition","volume":"12","author":"Menzies","year":"2022","journal-title":"Sci Rep."},{"key":"10.1016\/j.drudis.2026.104841_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e25531","article-title":"Revolutionizing snakebite care with novel antivenoms: breakthroughs and barriers","volume":"10","author":"Uko","year":"2024","journal-title":"Heliyon."},{"key":"10.1016\/j.drudis.2026.104841_b0275","article-title":"Aptamer-based nanotrains and nanoflowers as quinine delivery systems","volume":"5","author":"Cao","year":"2023","journal-title":"Int J Pharm X."},{"key":"10.1016\/j.drudis.2026.104841_b0280","article-title":"A chimeric RNA consisting of siRNA and aptamer for inhibiting dengue virus replication. NAR","volume":"1","author":"Amano","year":"2024","journal-title":"Mol Med."},{"key":"10.1016\/j.drudis.2026.104841_b0285","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/v13050881","article-title":"Rabies prophylactic and treatment options: an in vitro study of siRNA- and aptamer-based therapeutics","volume":"13","author":"Scott","year":"2021","journal-title":"Viruses."},{"key":"10.1016\/j.drudis.2026.104841_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.128557","article-title":"Aptamer and RVG functionalized gold nanorods for targeted photothermal therapy of neurotropic virus infection in the mouse brain","volume":"411","author":"Ren","year":"2021","journal-title":"Chem Eng J."},{"key":"10.1016\/j.drudis.2026.104841_b0295","doi-asserted-by":"crossref","first-page":"16661","DOI":"10.1021\/jacs.5c04975","article-title":"Rabies virus targeting NIR-II phototheranostics","volume":"147","author":"Ding","year":"2025","journal-title":"J Am Chem Soc."},{"key":"10.1016\/j.drudis.2026.104841_b0300","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/cbic.201800674","article-title":"Bioinspired design of lysolytic triterpenoid\u2013peptide conjugates that kill African trypanosomes","volume":"20","author":"Leeder","year":"2019","journal-title":"ChemBioChem."},{"key":"10.1016\/j.drudis.2026.104841_b0305","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12916-018-1188-2","article-title":"The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review","volume":"16","author":"Haeusler","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.drudis.2026.104841_b0310","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.7150\/thno.23085","article-title":"Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1","volume":"8","author":"Zhou","year":"2018","journal-title":"Theranostics."},{"key":"10.1016\/j.drudis.2026.104841_b0315","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3201\/eid2610.200232","article-title":"Inappropriate administration of rabies postexposure prophylaxis, Cook County, Illinois, USA","volume":"26","author":"Steinberg","year":"2020","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.drudis.2026.104841_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2020.105459","article-title":"Dog rabies control in West and Central Africa: a review","volume":"224","author":"Mbilo","year":"2021","journal-title":"Acta Trop."},{"key":"10.1016\/j.drudis.2026.104841_b0325","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijid.2024.01.008","article-title":"Rabies vaccinations save lives but where are the vaccines? Global vaccine inequity and escalating rabies-related mortality in low- and middle-income countries","volume":"140","author":"Alemayehu","year":"2024","journal-title":"Int J Infect Dis."},{"key":"10.1016\/j.drudis.2026.104841_b0330","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/S1473-3099(22)00641-7","article-title":"Human rabies despite post-exposure prophylaxis: a systematic review of fatal breakthrough infections after zoonotic exposures","volume":"23","author":"Whitehouse","year":"2023","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.drudis.2026.104841_b0335","unstructured":"World Health Organization. Trypanosomiasis, human African (sleeping sickness). Accessed 10 April 2026. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/trypanosomiasis-human-african-(sleeping-sickness); 2023. Updated 2 May 2023."},{"key":"10.1016\/j.drudis.2026.104841_b0340","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","article-title":"Human African trypanosomiasis","volume":"390","author":"B\u00fcscher","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.drudis.2026.104841_b0345","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.drudis.2026.104841_b0350","article-title":"Recent progress in diagnosis and treatment of human African trypanosomiasis has made the elimination of this disease a realistic target by 2030","volume":"9","author":"\u00c1lvarez-Rodr\u00edguez","year":"2022","journal-title":"Front Med (Lausanne)."},{"key":"10.1016\/j.drudis.2026.104841_b0355","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/tropicalmed5010029","article-title":"New drugs for human African trypanosomiasis: a twenty first century success story","volume":"5","author":"Dickie","year":"2020","journal-title":"Trop Med Infect Dis."},{"key":"10.1016\/j.drudis.2026.104841_b0360","unstructured":"World Health Organization. Antimicrobial resistance. Accessed 25 April 2026. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance; 2023. Updated 21 November 2023."},{"key":"10.1016\/j.drudis.2026.104841_b0365","unstructured":"Centers for Disease Control and Prevention. Drug resistance in the malaria-endemic world. Accessed 25 April 2026. https:\/\/www.cdc.gov\/malaria\/php\/public-health-strategy\/drug-resistance.html; 2024. Updated 3 April 2024."},{"key":"10.1016\/j.drudis.2026.104841_b0370","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3390\/pathogens13100835","article-title":"Molecular mechanisms of drug resistance in Leishmania spp","volume":"13","author":"Moncada-Diaz","year":"2024","journal-title":"Pathogens."},{"key":"10.1016\/j.drudis.2026.104841_b0375","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat Rev Drug Discov."},{"key":"10.1016\/j.drudis.2026.104841_b0380","doi-asserted-by":"crossref","DOI":"10.1155\/bmri\/8847267","article-title":"Antimicrobial multidrug resistance and mechanisms of action: an overview","volume":"2025","author":"Temesgen","year":"2025","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.drudis.2026.104841_b0385","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00153-23","article-title":"Transforming the chemotherapy of human African trypanosomiasis","volume":"38","author":"Barrett","year":"2025","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.drudis.2026.104841_b0390","article-title":"Prodrug activation in malaria parasites mediated by an imported erythrocyte esterase, acylpeptide hydrolase (APEH)","author":"Sundararaman","year":"2025","journal-title":"bioRxiv."},{"key":"10.1016\/j.drudis.2026.104841_b0395","doi-asserted-by":"crossref","first-page":"14407","DOI":"10.1038\/s41598-017-14986-6","article-title":"Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole","volume":"7","author":"Campos","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.drudis.2026.104841_b0400","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/genes9110529","article-title":"Aptamer chimeras for therapeutic delivery: the challenging perspectives","volume":"9","author":"Esposito","year":"2018","journal-title":"Genes (Basel)."},{"key":"10.1016\/j.drudis.2026.104841_b0405","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.3390\/ijms25115616","article-title":"Rabies virus infection causes pyroptosis of neuronal cells","volume":"25","author":"Yu","year":"2024","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.drudis.2026.104841_b0410","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1021\/acs.accounts.5c00488","article-title":"Precision phototherapy enabled by decoding complex microenvironments","volume":"58","author":"Ding","year":"2025","journal-title":"Acc Chem Res."},{"key":"10.1016\/j.drudis.2026.104841_b0415","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3390\/pathogens14111132","article-title":"Dengue virus and the host immune system: a battle of immune modulation, response and evasion","volume":"14","author":"Ghosh","year":"2025","journal-title":"Pathogens."},{"key":"10.1016\/j.drudis.2026.104841_b0420","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/pathogens13080639","article-title":"Evaluation of four humanized NOD-derived mouse models for dengue virus-2 infection","volume":"13","author":"Gutierrez-Barbosa","year":"2024","journal-title":"Pathogens."},{"key":"10.1016\/j.drudis.2026.104841_b0425","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.830384","article-title":"Rodent lethality models are problematic for evaluating antivenoms for human envenoming","volume":"13","author":"Silva","year":"2022","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.drudis.2026.104841_b0430","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/cpt.2545","article-title":"Understanding the blood-brain barrier and beyond: challenges and opportunities for novel CNS therapeutics","volume":"111","author":"de Lange","year":"2022","journal-title":"Clin Pharmacol Ther."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626002461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626002461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:25:07Z","timestamp":1792988707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626002461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":86,"alternative-id":["S1359644626002461"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104841","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aptamer-based therapeutics for malaria and neglected tropical diseases","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104841"}}